Patents by Inventor Gaston-Jacques Godeau

Gaston-Jacques Godeau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10105393
    Abstract: The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerization of said native EPSs followed by a step of sulphating the resulting depolymerized derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 ?g (m) g/ml.
    Type: Grant
    Filed: August 10, 2015
    Date of Patent: October 23, 2018
    Assignees: INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER), UNIVERSITE RENE DESCARTES PARIS 5
    Inventors: Karim Senni, Farida Gueniche, Myriam Yousfi, Florence Fioretti, Gaston-Jacques Godeau, Sylvia Colliec-Jouault, Jacqueline Ratiskol, Corinne Sinquin, Gérard Raguenes, Anthony Courtois, Jean Guezennec
  • Publication number: 20150344848
    Abstract: The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 ?g (m) g/ml.
    Type: Application
    Filed: August 10, 2015
    Publication date: December 3, 2015
    Inventors: Karim Senni, Farida Gueniche, Myriam Yousfi, Florence Fioretti, Gaston-Jacques Godeau, Sylvia Colliec-Jouault, Jacqueline Ratiskol, Corinne Sinquin, Gérard Raguenes, Anthony Courtois, Jean Guezennec
  • Patent number: 9125883
    Abstract: The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerization of said native EPSs followed by a step of sulphating the resulting depolymerized derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 ?g (m) g/ml.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: September 8, 2015
    Assignees: INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER), UNIVERSITE RENE DESCARTES PARIS 5
    Inventors: Karim Senni, Farida Gueniche, Myriam Yousfi, Florence Fioretti, Gaston-Jacques Godeau, Sylvia Colliec-Jouault, Jacqueline Ratiskol, Corinne Sinquin, Gérard Raguenes, Anthony Courtois, Jean Guezennec
  • Publication number: 20140037597
    Abstract: The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 ?g (m) g/ml.
    Type: Application
    Filed: October 11, 2013
    Publication date: February 6, 2014
    Applicants: UNIVERSITY RENE DESCARTES PARIS 5, INSTITUT FRANCAIS DE RECHERCHE POUR L' EXPLOITATION DE LA MER (IFREMER)
    Inventors: Karim Senni, Farida Gueniche, Myriam Yousfi, Florence Fioretti, Gaston-Jacques Godeau, Sylvia Colliec-Jouault, Jacqueline Ratiskol, Corinne Sinquin, Gérard Raguenes, Anthony Courtois, Jean Guezennec
  • Patent number: 8598142
    Abstract: The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 ?g (m) g/ml.
    Type: Grant
    Filed: January 7, 2011
    Date of Patent: December 3, 2013
    Assignees: Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER), Universite Rene Descartes Paris 5
    Inventors: Karim Senni, Farida Gueniche, Myriam Yousfi, Florence Fioretti, Gaston-Jacques Godeau, Sylvia Colliec-Jouault, Jacqueline Ratiskol, Corinne Sinquin, Gérard Raguenes, Anthony Courtois, Jean Guezennec
  • Publication number: 20110305647
    Abstract: The invention relates to the use of a polysaccharide which is excreted by the Vibrio diabolicus species for the regeneration and protection of the non-mineralised connective tissue of the periodontium.
    Type: Application
    Filed: June 17, 2011
    Publication date: December 15, 2011
    Applicant: INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER)
    Inventors: Karim SENNI, Corinne SINQUIN, Sylvia COLLIEC-JOUAULT, Gaston-Jacques GODEAU, Jean GUEZENNEC
  • Publication number: 20110245199
    Abstract: The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 ?g (m) g/ml.
    Type: Application
    Filed: January 7, 2011
    Publication date: October 6, 2011
    Applicants: INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER), UNIVERSITE RENE DESCARTES PARIS 5
    Inventors: Karim Senni, Farida Gueniche, Myriam Yousfi, Florence Fioretti, Gaston-Jacques Godeau, Sylvia Colliec-Jouault, Jacqueline Ratiskol, Corinne Sinquin, Gérard Raguenes, Anthony Courtois, Jean Guezennec
  • Patent number: 7951391
    Abstract: The present invention relates to the use of fucans with a weight-average molar mass of between 5000 and 100 000 g/mol, for the purposes of bone grafting, engineering and regeneration.
    Type: Grant
    Filed: February 21, 2007
    Date of Patent: May 31, 2011
    Assignees: Universite Rene Descartes Paris 5, Institut Francais de Recherche pour l'Exploitation de la Mer (IFREMER)
    Inventors: Sylvie Igondjo-Tchen Changotade, Karim Senni, Alexandrine Foucault-Bertaud, Grégory Korb, Maya Brigitte Baroukh, Jean-Louis Saffar, Gaston-Jacques Godeau, Corinne Sinquin, Sylvia Colliec-Jouault, Patrick Durand
  • Publication number: 20090043399
    Abstract: The present invention relates to the use of fucans with a weight-average molar mass of between 5000 and 100 000 g/mol, for the purposes of bone grafting, engineering and regeneration.
    Type: Application
    Filed: February 21, 2007
    Publication date: February 12, 2009
    Applicant: INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (FREMER)
    Inventors: Sylvie Igondjo-Tchen Changotade, Karim Senni, Alexandrine Foucault-Bertaud, Gregory Korb, Maya Brigitte Baroukh, Jean-Louis Saffar, Gaston-Jacques Godeau, Corinne Sinquin, Sylvia Colliec-Jouault, Patrick Durand
  • Publication number: 20090028924
    Abstract: The invention relates to the use of a polysaccharide which is excreted by the Vibrio diabolicus species for the re-generation and protection of the non-mineralised connective tissue of the periodontium.
    Type: Application
    Filed: December 6, 2007
    Publication date: January 29, 2009
    Applicant: UNIVERSITE RENE DESCARTES PARIS 5
    Inventors: Karim Senni, Corinne Sinquin, Sylvia Colliec-Jouault, Gaston-Jacques Godeau, Jean Guezennec
  • Publication number: 20080317860
    Abstract: The invention relates to the use of a polysaccharide which is excreted by the Vibrio diabolicus species for the engineering of non-mineralised connective tissues, in particular for skin and cartilage engineering.
    Type: Application
    Filed: December 6, 2006
    Publication date: December 25, 2008
    Applicants: INSTITUT FRANCAIS DE RECHERCHE POUR L'EXPLOITATION DE LA MER (IFREMER), UNIVERSITE RENE DESCARTES PARIS 5
    Inventors: Karim Senni, Corinne Sinquin, Sylvia Colliec-Jouault, Gaston-Jacques Godeau, Jean Guezennec
  • Publication number: 20080131472
    Abstract: The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 ?g(m)g/ml.
    Type: Application
    Filed: June 6, 2005
    Publication date: June 5, 2008
    Applicant: UNIVERSITE RENE DESCARTIES PARIS 5
    Inventors: Karim Senni, Farida Gueniche, Myriam Yousfi, Florence Fioretti, Gaston-Jacques Godeau, Sylvia Colliec-Jouault, Jacqueline Ratiskol, Corinne Sinquin, Gerard Raguenes, Anthony Courtois, Jean Guezennec